Research

February 20, 2023

Probing hellbender health

Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.

By Leigh MacMillan
February 16, 2023

Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.

By Leigh MacMillan
February 16, 2023

Targeted therapy for neuroendocrine tumors

Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.

By Kelsey Pinckard
The study found that chronically disrupted sleep and highly variable sleep durations night after night may increase the risk for atherosclerosis.
February 15, 2023

Study finds chronically disrupted sleep may increase risk for heart disease

Vanderbilt research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.

By Bill Snyder
From left, Paula Donahue, PT, DPT, MBA, Aaron Aday, MD, MSc, and Rachelle Crescenzi, PhD, are part of a multidisciplinary effort at VUMC to improve the diagnosis and treatment of lipedema.
February 9, 2023

Team’s imaging strategy enhances lipedema treatment

A collaborative team at Vanderbilt is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.

By Bill Snyder
February 7, 2023

A new view of a cholesterol carrier

Vanderbilt researchers developed a novel method to measure small RNAs carried by HDL and demonstrated that these molecules circulate in greater concentrations than previously believed and are likely to contribute to communication between immune cells.

By Kelsey Pinckard 
February 6, 2023

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Vanderbilt University Medical Center's ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.
By Bill Snyder
February 6, 2023

Gut microbiota and lung fibrosis

Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.
By Leigh MacMillan
February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.
By Sarah E. Glass
February 2, 2023

Researchers clarify role of blood cell mutations in disease

Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.
By Bill Snyder
February 2, 2023

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

By Bill Snyder
February 2, 2023

Nutrient absorption disease model

Vanderbilt researchers developed a model of a patient-specific mutation to explore the pathology of microvillus inclusion disease, a genetic disorder that causes life-threatening diarrhea.
By Leigh MacMillan
February 2, 2023

Machine learning aids injury prevention in cardiac cath labs

By Paul Govern
1 … 10 11 12 13 14 … 54